Confluence Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$583K Buy
17,109
+3,433
+25% +$120K 0.29% 72
2020
Q2
$424K Buy
13,676
+713
+6% +$24.2K 0.2% 81
2020
Q1
$401K Sell
12,963
-3,400
-21% -$116K 0.22% 81
2019
Q4
$608K Sell
16,363
-746
-4% -$26.6K 0.28% 76
2019
Q3
$583K Buy
17,109
+518
+3% +$18.8K 0.29% 72
2019
Q2
$682K Sell
16,591
-1,439
-8% -$57.1K 0.33% 70
2019
Q1
$726K Buy
18,030
+619
+4% +$24.8K 0.36% 65
2018
Q4
$721K Sell
17,411
-883
-5% -$36.7K 0.4% 62
2018
Q3
$765K Buy
18,294
+562
+3% +$21.6K 0.4% 62
2018
Q2
$610K Buy
17,732
+8,103
+84% +$277K 0.32% 70
2018
Q1
$324K Buy
9,629
+2,688
+39% +$92.4K 0.17% 100
2017
Q4
$239K Buy
+6,941
New +$237K 0.11% 117
2014
Q3
Sell
-19,490
Closed -$549K 107
2014
Q2
$549K Buy
+19,490
New +$556K 0.31% 77

Other funds holding PFE

Confluence Wealth Management's PFE Position: Q3 2020 in Review

Confluence Wealth Management increased its Pfizer (PFE) stake by 25% in Q3 2020, buying an estimated $120K and bringing the position to 17,109 shares worth $583K. The position accounts for 0.29% of the portfolio, ranked #72.

Confluence Wealth Management first reported a position in PFE in Q2 2014 and has held it in 13 quarters since. The position peaked at $765K in Q3 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Confluence Wealth Management held 17,109 shares of Pfizer worth $583K as of Q3 2020.
  • Confluence Wealth Management bought 3,433 Pfizer shares in Q3 2020, an estimated $120K.
  • Pfizer made up 0.29% of Confluence Wealth Management's portfolio in Q3 2020, its #72 holding.
  • Confluence Wealth Management first reported a position in Pfizer in Q2 2014 and has held it in 13 quarters since.
  • Confluence Wealth Management's Pfizer position peaked at $765K in Q3 2018.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.